No Data
No Data
H.C. Wainwright Initiates Virax Biolabs(VRAX.US) With Buy Rating, Announces Target Price $3
Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating
HC Wainwright & Co. Initiates Coverage On Virax Biolabs Group With Buy Rating, Announces Price Target of $3
Virax Biolabs Group Analyst Ratings
Express News | Virax Biolabs Enrolls First Patients In Its UK Based Clinical Study Assessing T Cell Dysfunction In Post-acute Infection Syndromes
Virax Biolabs Enrolls First Patients in Clinical Study Assessing T Cell Dysfunction in Post-acute Infection Syndromes